Futura Medical plc (AIM:FUM)

Market Cap	25.61M
Revenue (ttm)	13.93M
Net Income (ttm)	1.29M
Shares Out	303.83M
EPS (ttm)	0.00
PE Ratio	20.56
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	621,678
Average Volume	425,349
Open	8.98
Previous Close	8.43
Day's Range	7.60 - 8.98
52-Week Range	7.60 - 45.56
Beta	0.83
RSI	41.06
Earnings Date	Jun 10, 2025

About Futura Medical

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM